Krešimir Krnjević (1927–2021) and GABAergic inhibition: a lifetime dedication-Reference-Cited by-同舟云学术

Krešimir Krnjević (1927–2021) and GABAergic inhibition: a lifetime dedication

Published:2022-01 Issue:1 Volume:100 Page:1-4
ISSN:0008-4212
Container-title:Canadian Journal of Physiology and Pharmacology
language:en
Short-container-title:Can. J. Physiol. Pharmacol.

Author:

Ben-Ari Yehezkel¹,Cherubini Enrico²,Avoli Massimo³

Affiliation:

1. Neurochlore, Campus Scientifique de Luminy, 13288 Marseille Cedex 09, France.

2. European Brain Research Institute Rita Levi-Montalcini, 00161 Roma, Italy.

3. Montreal Neurological Institute-Hospital and Departments of Neurology & Neurosurgery and of Physiology, McGill University, Montreal, H3A 2B4 QC, Canada.

Abstract

After over seven decades of neuroscience research, it is now well established that γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain. In this paper dedicated to Krešimir Krnjević (1927–2021), a pioneer and leader in neuroscience, we briefly highlight the fundamental contributions he made in identifying GABA as an inhibitory neurotransmitter in the brain and our personal interactions with him. Of note, between 1972 and 1978 Dr. Krnjević was a highly reputed Chief Editor of the Canadian Journal of Physiology and Pharmacology.

Publisher

Canadian Science Publishing

Subject

Physiology (medical),Pharmacology,General Medicine,Physiology

Link

https://cdnsciencepub.com/doi/pdf/10.1139/cjpp-2021-0451

Reference32 articles.

1. The Long and Winding Road to Gamma-Amino-Butyric Acid as Neurotransmitter

2. On the synchronous activity induced by 4-aminopyridine in the CA3 subfield of juvenile rat hippocampus

3. Synchronous GABA-Mediated Potentials and Epileptiform Discharges in the Rat Limbic SystemIn Vitro

4. Factor I and γ-Aminobutyric Acid

5. The GABA excitatory/inhibitory developmental sequence: A personal journey

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infra-Low Frequency Neurofeedback rapidly ameliorates schizophrenia symptoms: A case report of the first session;Frontiers in Human Neuroscience;2022-09-21

2. Parvalbumin Role in Epilepsy and Psychiatric Comorbidities: From Mechanism to Intervention;Frontiers in Integrative Neuroscience;2022-02-17